Search results

This guide provides an overview of the principles and methods of health technology assessment and appraisal within the context of the NICE appraisal process

This manual explains how NICE develops and updates social care guidance. It provides advice on the technical aspects of guidance development and the methods used

How to use NICE guidance to reduce health inequalities in people experiencing cardiovascular disease (CVD).

Help make a difference on behalf of the people most affected by our recommendations on our voluntary and community sector forum.

Evidence-based recommendations on percutaneous insertion of a cystic duct stent after cholecystostomy for acute calculous cholecystitis. This involves inserting a tube called a stent into or across the cystic duct. The aim is to allow bile to flow through the tube, bypassing the blockage and preventing further obstruction.

Result type

HealthTech guidance

Published

9 March 2022

In a virtual ward setting, you make assessments at home to support clinical decision-making. Our guidance can help you give advice by highlighting areas to consider and standards of care.

Highly specialised technology (HST) evaluations are recommendations on the use of new and existing highly specialised medicines and treatments within the NHS in England.

Learn about the NICE Technology Appraisal and Highly Specialised Technologies appeals process, including how decisions are made, the criteria for appeals, and the role of the appeal panel in ensuring fair and transparent evaluations of health technologies.

Each year we work with NHSE and the DHSC to prioritise topics for development.

Tell us about an interventional procedure you think should be assessed by NICE.

Our centralised approach to prioritising guidance topics ensures that we produce guidance that is relevant, timely, accessible, and has demonstrable impact.

Our centralised approach to prioritising our guidance topics ensures that we produce guidance that's relevant, timely, accessible, and has demonstrable impact.

Summaries of the best available evidence for selected medicines that are considered to be of significance to the NHS.

We want you to be involved in our work - whether you’re commenting on our draft recommendations, taking part in guidance development or attending a committee meeting, your voice is important to us.

NICE Advice - a fee-based advisory service for pharmaceutical and healthtech companies seeking to enter the NHS market,